2025-10-20T15:28:56-05:00 2024-12-31 411360831 OLSEN THIELEN & CO LTD 2675 LONG LAKE ROAD ST PAUL MN 55113 990 2024-01-01 411893645 CHILDREN'S CANCER RESEARCH FUND CHIL 9528939355 1650 W 82ND ST 400 MINNEAPOLIS MN 55431 ELIZABETH ALLEN CHIEF EXECUTIVE OFFICER 9528939355 2025-10-20 1 1 RYAN VETTRUS CPA P01243596 6514834521 2024 2025-03-06 01:10:19Z ELIZABETH ALLEN 1650 W 82ND ST 400 MINNEAPOLIS MN 55431 20064992 0 X WWW.CHILDRENSCANCER.ORG X 1997 MN CHILDREN'S CANCER RESEARCH FUND FUELS TRANSFORMATIONAL RESEARCH TO BRING BETTER TREATMENTS AND CURES TO CHILDREN WITH CANCER. 18 17 52 68 0 0 17954505 18237103 0 0 324486 865489 106773 -198696 18385764 18903896 5840759 5676081 0 0 4216447 4169739 0 0 3463887 8246125 8066765 18303331 17912585 82433 991311 16414111 17538090 9968654 10004026 6445457 7534064 X CHILDREN'S CANCER RESEARCH FUND FUELS TRANSFORMATIONAL RESEARCH TO BRING BETTER TREATMENTS AND CURES TO CHILDREN WITH CANCER. 0 0 6321697 5676081 0 RESEARCH AND GRANTING PROGRAMS:IN 2024, CCRF AWARDED NEARLY $6 MILLION AS RESEARCH AND PROGRAM GRANTS IN THE FOLLOWING AREAS OF FOCUS: - HARD-TO-TREAT CANCERS: CCRF PRIORITIZES RESEARCH FOR CANCERS WITH PERSISTENTLY LOW SURVIVAL RATES. THESE INCLUDE HIGHLY AGGRESSIVE AND OFTEN FATAL CANCERS SUCH AS BRAIN TUMORS, SARCOMAS, AND CERTAIN TYPES OF LEUKEMIAS. IN 2024, WE AWARDED $1,000,000 TO SUPPORT A CLINICAL TRIAL ON RELAPSED WILMS TUMOR LED BY A RESEARCHER AT MEMORIAL SLOAN KETTERING. WE ALSO AWARDED A TOTAL OF $500,000 TO TWO ADDITIONAL RESEARCHERS AT MEMORIAL SLOAN KETTERING TO SUPPORT CLINICAL TRIALS ON A PARTICULARLY HARD-TO-TREAT TYPE OF ACUTE MYELOID LEUKEMIA (AML) AND PEDIATRIC SOLID TUMORS. IN ADDITION, CCRF AWARDED MORE THAN $1,000,000 TO RESEARCHERS AT MULTIPLE RESEARCH INSTITUTIONS FOR WORK ON CANCERS INCLUDING RHABDOMYOSARCOMA, OSTEOSARCOMA, BRAIN TUMORS AND HEPATOBLASTOMA. FINALLY, CCRF MADE A GRANT OF $2,000,000 TO ESTABLISH AN ENDOWED CHAIR IN PEDIATRIC BRAIN TUMOR RESEARCH AT THE UNIVERSITY OF MINNESOTA. - SURVIVORSHIP: MANY CHILDHOOD CANCER SURVIVORS LIVE WITH ENDURING CONSEQUENCES OF CHEMOTHERAPY, RADIATION, OR SURGICAL INTERVENTIONS, INCLUDING COGNITIVE IMPAIRMENT, CARDIAC ISSUES AND INFERTILITY. CCRF SUPPORTS RESEARCHERS DOING WORK ON NEW TREATMENT MODALITIES THAT WILL REDUCE ADVERSE LONG-TERM EFFECTS, INTERVENTIONS TO PROMOTE HEALTH AMONG SURVIVORS, AND OTHER STRATEGIES TO MITIGATE ADVERSE LONG-TERM EFFECTS. IN 2024, CCRF GRANTED A TOTAL OF $600,000 TO RESEARCHERS AT CHILDREN'S NATIONAL, THE UNIVERSITY OF MICHIGAN AND THE UNIVERSITY OF MINNESOTA FOR STUDIES FOCUSED ON HEALTHY SURVIVORSHIP.- HEALTH DISPARITIES: DISPARITIES IN PEDIATRIC CANCER OUTCOMES ARE INFLUENCED BY FACTORS INCLUDING RACE, ETHNICITY AND SOCIOECONOMIC BACKGROUND. CCRF SUPPORTS RESEARCH ON DISPARITIES IN CANCER OUTCOMES, WITH PARTICULAR ATTENTION PAID TO INTERVENTIONS AIMED AT PREVENTING OR MITIGATING THEM. IN 2024, CCRF AWARDED $250,000 TO RESEARCH LOOKING AT THE IMPACT OF FAMILY INCOME ON OUTCOMES FOR CHILDREN WITH LEUKEMIA. 5969559 0 0 EDUCATION AND AWARENESS PROGRAM:IN ADDITION TO FUNDING RESEARCH AND OFFERING SUPPORT PROGRAMS, WE GENERATE AWARENESS ABOUT THE NEED FOR CHILDHOOD CANCER RESEARCH AND PROVIDE EDUCATIONAL RESOURCES FOR RESEARCHERS. WE REACH MILLIONS OF PEOPLE THROUGH OUR WEBSITE, DIGITAL AND SOCIAL MEDIA PLATFORMS, AND IN-KIND TELEVISION AND PRINT ADVERTISING TO SHARE THE STORIES OF KIDS, FAMILIES, AND RESEARCHERS. WE'RE ALSO PROUD TO SUPPORT THE CANCER SURVIVORSHIP CONFERENCE, THE MARK E. NESBIT LECTURESHIP IN PEDIATRIC ONCOLOGY, AND THE NORMA K.C. RAMSAY, MD, DISTINGUISHED VISITING PROFESSOR LECTURESHIP SERIES. THESE BRING NATIONALLY RECOGNIZED CHILDHOOD CANCER EXPERTS TO MINNESOTA TO SPEAK ON CURRENT SURVIVORSHIP, CLINICAL AND RESEARCH ISSUES, AS WELL AS BUILD NEW RESEARCH COLLABORATIONS. 657234 0 0 FAMILY SUPPORT PROGRAMS:OUR DEDICATED FAMILY PROGRAMS IMPROVE THE WELL-BEING OF KIDS AND FAMILIES AS THEY NAVIGATE THE DIFFICULT EXPERIENCES OF CANCER TREATMENT, SURVIVORSHIP, OR BEREAVEMENT. THESE OFFERINGS INCLUDE: - THE BIG DREAMS TOUR - A CREATIVE OUTLET THAT REDUCES ISOLATION BY LEVERAGING AR, VR, AND XR TECHNOLOGY TO PROVIDE PEDIATRIC CANCER PATIENTS AN OPPORTUNITY TO GAME TOGETHER MONTHLY AND CREATE THEIR OWN ANIMATED MUSIC VIDEO, VIDEO GAME, OR VFX VIDEO; INCLUDING COMMUNITY EVENTS WHERE THEIR CREATIONS ARE BROUGHT TO LIFE IN VIRGINIA, MICHIGAN, MAINE AND MINNESOTA. - CAMP NORDEN - IN-PERSON AND VIRTUAL FIVE-DAY SUMMER CAMPS ARE DESIGNED ESPECIALLY TO MEET THE UNIQUE NEEDS OF CHILDREN WHO HAVE BEEN DIAGNOSED WITH CANCER AND SUPPORT FRIENDSHIP-BUILDING, SOLIDARITY WITH PEERS, INCREASED SELF-ESTEEM, AND A FEELING OF INDEPENDENCE. THESE CAMPS FOSTER COMMUNITY AND ELIMINATE FINANCIAL OR GEOGRAPHICAL BARRIERS TO ATTEND.-CC BEAR- OUR CURE CANCER "C.C." BEAR IS READY TO COMFORT AND CARE FOR THOSE WHO NEED HIM MOST AT NO COST TO FAMILIES. 619 BEARS WERE SENT TO CHILDREN WITH CANCER, AND THEIR SIBLINGS. 12948490 1 1 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 0 0 0 0 0 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 32 0 1 52 1 0 0 0 0 0 1 1 0 0 0 1 0 0 0 X 18 17 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 MN AL AR CA CT FL GA HI IL KS KY MA MD MI MA NC NH NJ NM NY OK OR PA RI SC TN UT VA WI WV X X THE ORGANIZATION 9528939355 1650 W 82ND ST 400 MINNEAPOLIS MN 55431 JEAN MACHART COO THROUGH SEPTEMBER 40.00 X X 260067 0 12097 ELIZABETH ALLEN CEO 40.00 X X 244491 0 9874 KENNA DOOLEY CHIEF DEVELOPMENT OFFICER 40.00 X 202605 0 14192 ERSKINE BEVEL DIRECTOR OF FINANCE 40.00 X 150270 0 13186 RYAN DURRY DIRECTOR, BRAND & COMMUNICATIONS 40.00 X 121289 0 23015 MARY MAIDEN MUELLER ASSOC DIRECTOR, TECHNOLOGY/ANALYTICS 40.00 X 118458 0 26538 MICHELLE TUMA SENIOR ACCOUNTING MANAGER 40.00 X 113881 0 28789 JOHN GOLDEN CHAIRPERSON 1.00 X X 0 0 0 ABBIE MILLER MD VICE CHAIRPERSON 1.00 X X 0 0 0 SUSAN DOHERTY IMMEDIATE PAST CHAIR 1.00 X X 0 0 0 JEN WILSON TREASURER 1.00 X X 0 0 0 MEGHAN HARRIS SECRETARY 1.00 X X 0 0 0 CHRIS ZUPFER VICE CHAIR ELECT 1.00 X X 0 0 0 ADAM CHOE DIRECTOR 1.00 X 0 0 0 HEIKE DRAKE-CAVALLETTI DIRECTOR 1.00 X 0 0 0 BARB FARRELL DIRECTOR 1.00 X 0 0 0 MEGAN GOODRICH DIRECTOR 1.00 X 0 0 0 MICHAEL HARRIS DIRECTOR 1.00 X 0 0 0 MICHELLE JOHNSON DIRECTOR 1.00 X 0 0 0 MOLLY KINSELLA DIRECTOR 1.00 X 0 0 0 DAWN LAMM DIRECTOR 1.00 X 0 0 0 GREG SOUKUP DIRECTOR 1.00 X 0 0 0 ASHLEY THRONSON DIRECTOR 1.00 X 0 0 0 CHRIS TOPPIN DIRECTOR 1.00 X 0 0 0 1211061 0 127691 9 0 1 0 THE EVENTS MOVEMENT USA 1650 W 82ND ST SUITE 400 MINNEAPOLIS MN 55431 EVENT PRODUCTION 1281217 DOUGLAS SHAW AND ASSOCIATES 1717 PARK STREET SUITE 300 NAPERVILLE IL 60563 PRINTING AND MAILING 717498 RR DONNELLEY 7810 SOLUTION CENTER CHICAGO IL 60677 PRINTING AND MAILING 410397 PSA3 LLC 89 HENDRICKSON PL FAIR HAVEN NJ 07704 PSA DISTRIBUTION 244000 NEMER FIEGER & ASSOCIATED INC 6250 EXCELSIOR BLVD 2023 MINNEAPOLIS MN 55416 ADVERTISING AND MARKETING SERVICES 238470 8 530822 17706281 2222704 18237103 233878 233878 1538487 906876 631611 631611 631611 13070 530822 254220 -241150 -241150 OTHER INCOME 900099 42454 42454 42454 18903896 42454 0 624339 5676081 5676081 526529 266102 140974 119453 3057832 1545393 818713 693726 85288 43104 22835 19349 254682 128714 68189 57779 245408 124027 65706 55675 22263 22263 33000 33000 22304 22304 1566226 1393020 2840 170366 3708577 1990265 1 1718311 401723 346143 9151 46429 182939 80590 55404 46945 193291 97687 51752 43852 54799 27694 14673 12432 226406 114422 60620 51364 35122 17750 9404 7968 DIRECT MAIL EXPENSES 1033144 729892 303252 FEES, LICENSES AND PERM 563130 249849 85160 228121 VENUE AND ENTERTAINMENT 193934 90773 2922 100239 TRAINING AND DEVELOPMEN 53394 26984 14297 12113 -223487 -223487 17912585 12948490 1500208 3463887 X 3857500 2645000 0 1212500 5020292 7444970 3339667 2570318 1652632 1028868 89688 193598 1030404 664600 504204 365804 4622297 4884022 1185331 1050510 16414111 17538090 468526 1180441 8314577 7629529 1185551 1194056 9968654 10004026 X 4182014 4336541 2263443 3197523 6445457 7534064 16414111 17538090 991311 97296 0 X X 0 1 X 1 0 X 21914555 21100949 18617613 17954505 18237103 97824725 21914555 21100949 18617613 17954505 18237103 97824725 1037915 96786810 79454 97784 97890 172078 233878 681084 47355 40171 69543 42294 42454 241817 98747626 1743771 0.98010 0.99110 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: OTHER INCOME - 2020 AMOUNT: $ 47,355. 2021 AMOUNT: $ 40,171. 2022 AMOUNT: $ 69,543. 2023 AMOUNT: $ 42,294. 2024 AMOUNT: $ 42,454. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 884407 139474 50000 973881 739333 145074 884407 889385 -150052 739333 745506 143879 889385 622580 50000 72926 745506 0.00000 0.54713 0.45287 0 0 1030404 664600 365804 365804 ACCRUED INTEREST RECEIVABLE 2466 OPERATING LEASE RIGHT-OF-USE 1048044 1050510 OPERATING LEASE OBLIGATION 1194056 1194056 X 28582408 97296 9380033 9477329 19105079 22304 -223487 -201183 18903896 27493801 9380033 223487 9603520 17890281 22304 22304 17912585 PART V, LINE 4: THE PURPOSE OF THE ENDOWMENT FUNDS IS TO PROVIDE SUPPORT TO HELP ERADICATE CHILDHOOD CANCER. PART X, LINE 2: THE ORGANIZATION IS EXEMPT FROM FEDERAL AND STATE INCOME TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. THEREFORE, THE STATEMENTS DO NOT INCLUDE A PROVISION FOR INCOME TAXES BUT IS SUBJECT TO INCOME TAX ON NET UNRELATED BUSINESS INCOME. THE ORGANIZATION REVIEWS INCOME TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN INCOME TAX RETURNS TO DETERMINE IF THERE ARE ANY INCOME TAX UNCERTAINTIES. THIS INCLUDES POSITIONS THAT THE ENTITY IS EXEMPT FROM INCOME TAXES OR NOT SUBJECT TO INCOME TAXES ON UNRELATED BUSINESS INCOME. THE ORGANIZATION RECOGNIZES TAX BENEFITS FROM UNCERTAIN TAX POSITIONS ONLY IF IT IS MORE LIKELY THAN NOT THAT THE TAX POSITIONS WILL BE SUSTAINED ON EXAMINATION BY TAXING AUTHORITIES, BASED ON THE TECHNICAL MERITS OF THE POSITIONS. THE ORGANIZATION HAS IDENTIFIED NO INCOME TAX UNCERTAINTIES. THE ORGANIZATION FILES INFORMATION RETURNS AS A TAX-EXEMPT ORGANIZATION. SHOULD THAT STATUS BE CHALLENGED IN THE FUTURE, ALL YEARS SINCE INCEPTION COULD BE SUBJECT TO REVIEW BY THE IRS. PART XI, LINE 4B - OTHER ADJUSTMENTS: FUNDRAISING EXPENSES -223,487. PART XII, LINE 2D - OTHER ADJUSTMENTS: FUNDRAISING EXPENSES 223,487. AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY DAWN OF A DREAM 543892 530822 13070 357 79785 4145 4626 165307 543892 530822 13070 357 79785 4145 4626 165307 254220 -241150 1 CASE WESTERN RESERVE UNIVERSITY - SCHOOL OF MEDICINE 10900 EUCLID AVENUE CLEVELAND OH 44106 341018992 501(C)3 125000 0 DR. ALEX HUANG FOR OSTEOSARCOMA RESEARCH CHILDREN'S HOSPITAL OF PHILADELPHIA 2716 SOUTH STREET PHILADELPHIA PA 19146 231352166 501(C)3 650000 0 DR. JOHN MARIS FOR PEDIATRIC NEUROBLASTOMA RESEARCH CHILDREN'S HOSPITAL OF PHILADELPHIA 2716 SOUTH STREET PHILADELPHIA PA 19146 231352166 501(C)3 125000 0 DR. SOGOL MOSTOUFI-MOAB FOR RESEARCH ON IMPROVING CARE FOR THYROID CANCER SURVIVORS CHILDREN'S NATIONAL MEDICAL CENTER 111 MICHIGAN AVENUE NW WASHINGTON DC 20010 521654453 501(C)3 125000 0 DR. JENNIFER LEVINE FOR RESEARCH ON ALL SURVIVORS CHILDREN'S ONCOLOGY GROUP FOUNDATION INC 3501 CIVIC CENTER BLVD PHILADELPHIA PA 19104 453083156 501(C)3 50000 0 MINORITY YOUNG INVESTIGATORS AWARD DANA-FARBER CANCER INSTITUTE 450 BROOKLINE AVENUE BOSTON MA 02215 042263040 501(C)3 137500 0 DR. ALLISON O'NEILL FOR PEDIATRIC HEPATOBLASTOMA RESEARCH DANA-FARBER CANCER INSTITUTE 450 BROOKLINE AVENUE BOSTON MA 02215 042263040 501(C)3 125000 0 DR. BIRGIT KNOECHEL RESEARCH ON PEDIATRIC CANCER OUTCOMES DANA-FARBER CANCER INSTITUTE 450 BROOKLINE AVENUE BOSTON MA 02215 042263040 501(C)3 100000 0 DR. BRIAN CROMPTON HTT PROFILING CIRECULATING DNA DANA-FARBER CANCER INSTITUTE 450 BROOKLINE AVENUE BOSTON MA 02215 042263040 501(C)3 125000 0 DR. KIRA BONA FOR RESEARCH ON PEDIATRIC CANCER OUTCOMES IN LOW-INCOME FAMILIES FRED HUTCHINSON CANCER CENTER 1100 FAIRVIEW AVE N SEATTLE WA 98109 911935159 501(C)3 750095 0 DR. SOHEIL MESHINCHI FOR A CLINICAL TRIAL FOCUSED ON RARE AML JACKSONVILLE STATE UNIVERSITY 700 PELHAM ROAD JACKSONVILLE AL 36265 636001099 501(C)3 125000 0 DR. LE SU FOR CIC-DUX4 SARCOMA RESEARCH LAD IN A BATTLE LLC 109 WOODBRIDGE RD YORK ME 03909 472959863 25000 0 FOR VIRTUAL CAMP NORDEN FOR PEDIATRIC CANCER PATIENTS LAD IN A BATTLE LLC 109 WOODBRIDGE RD YORK ME 03909 472959863 175000 0 FOR BIG DREAMS TOUR MEMORIAL SLOAN KETTERING CANCER CENTER 1275 YORK AVENUE NEW YORK NY 10065 131924236 501(C)3 125000 0 DR. NEERAV SHUKLA FOR AML CLINICAL TRIAL MEMORIAL SLOAN KETTERING CANCER CENTER 1275 YORK AVENUE NEW YORK NY 10065 131924236 501(C)3 125000 0 DR. SAMEER SAIT FOR CLINICAL TRIAL OF NOVEL TREATMENT FOR PEDIATRIC SOLID TUMORS ST BALDRICK'S FOUNDATION 1333 S MAYFLOWER AVE MONROVIA CA 91016 201173824 501(C)3 100000 0 SUPERGRANT - DR. MITCHELL CAIRO FOR RESEARCH ON VIROIMMUNOTHERAPY FOR OSTEOSARCOMA ST BALDRICK'S FOUNDATION 1333 S MAYFLOWER AVE MONROVIA CA 91016 201173824 501(C)3 105000 0 SUPERGRANT - DR. PATRICK GROHAR RESEARCH ON MYC INHIBITORS FOR OSTEOSARCOMA THE RECTOR AND VISITORS OF THE UNIVERSITY OF VIRGINIA 1001 NORTH EMMET ST CHARLOTTESVILLE VA 22903 546001796 501(C)3 125000 0 DR. JOHN BUSHWELLER FOR RESEARCH ON MLL1 FUSION LEUKEMIA THE REGENTS OF THE UNIVERSITY OF CALIFORNIA - SAN FRANCISCO 490 ILLINOIS STREET SAN FRANCISCO CA 94143 946036493 501(C)3 125000 0 DR. WILLIAM WEISS FOR RESEARCH ON PFA EPENDYMOMA THE REGENTS OF THE UNIVERSITY OF MICHIGAN 5082 WOLVERINE TOWER 3003 S STATE STREET ANN ARBOR MI 481091287 386006309 501(C)3 150000 0 DR. ANAO ZHANG FOR RESEARCH ON PEDIATRIC CANCER SURVIVORS THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL DEPT 781653 PO BOX 78000 DETROIT MI 482781653 501(C)3 50000 0 DR. MARGOT LAZOW FOR RESEARCH ON PEDIATRIC BRAIN TUMOR AND CENTRAL NERVOUS SYSTEM CANCER UNIVERSITY OF CALIFORNIA - SAN FRANCISCO 490 ILLINOIS STREET SAN FRANCISCO CA 94143 946036493 501(C)3 125000 0 DR. ROSS OKIMOTO FOR CIC-DUX4 SARCOMA THERAPY RESEARCH UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE MINNEAPOLIS MN 55455 416042488 501(C)3 9166 0 FOR PEDIATRIC CANCER RESEARCH UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE MINNEAPOLIS MN 55455 416042488 501(C)3 28901 0 RESEARCH ON PEDIATRIC BRAIN TUMORS UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE MINNEAPOLIS MN 55455 416042488 501(C)3 214901 0 DR. BEAU WEBBER FOR OSTEOSARCOMA RESEARCH UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE MINNEAPOLIS MN 55455 416042488 501(C)3 148756 0 TO UNIVERSITY OF MINNESOTA FOR CGI EQUIPMENT UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE MINNEAPOLIS MN 55455 416042488 501(C)3 51079 0 DR. BEAU WEBBER'S RESEARCH ON EWING SARCOMA UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE MINNEAPOLIS MN 55455 416042488 501(C)3 113749 0 FOR KATIE HAGEBOECK SURVIVORSHIP FUND UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE MINNEAPOLIS MN 55455 416042488 501(C)3 109740 0 FOR PEDIATRIC CANCER RESEARCH UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE MINNEAPOLIS MN 55455 416042488 501(C)3 10776 0 FOR PEDIIATRIC BRAIN TUMOR RESEARCH UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE MINNEAPOLIS MN 55455 416042488 501(C)3 10000 0 FOR NORMA RAMSEY LECTURE SERIES UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE MINNEAPOLIS MN 55455 416042488 501(C)3 94523 0 FOR PEDIATRIC CANCER SURVIVORSHIP RESEARCH UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE MINNEAPOLIS MN 55455 416042488 501(C)3 46470 0 FOR PEDAIATRIC BRAIN TUMOR RESEARCH UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE MINNEAPOLIS MN 55455 416042488 501(C)3 48800 0 TO UNIVERSITY OF MINNESOTA FOR DR. JOHN WAGNER'S RESARCH UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE MINNEAPOLIS MN 55455 416042488 501(C)3 200000 0 RESEARCH ON PEDIATRIC BRAIN AND NEURAL TUMORS UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE MINNEAPOLIS MN 55455 416042488 501(C)3 150000 0 FOR PEDIATRIC CANCER RESEARCH UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE MINNEAPOLIS MN 55455 416042488 501(C)3 650000 0 CAPITAL FUND UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE MINNEAPOLIS MN 55455 416042488 501(C)3 300000 0 CADE FAMILY ENDOWED CHAIR UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE MINNEAPOLIS MN 55455 416042488 501(C)3 200000 0 CORRIGAN CGI EQUIPMENT UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE MINNEAPOLIS MN 55455 416042488 501(C)3 60000 0 OSTEOSARCOMA- DR. BEAU WEBBER UNIVERSITY OF ROCHESTER 910 GENESEE STREET ROCHESTER NY 14611 160743209 501(C)3 125000 0 DR. CAROL FRIES SIMPSON FOR RESEARCH ON INFANT ALL WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY 1300 YORK AVE NEW YORK NY 10065 131623978 501(C)3 125000 0 DR. JEFFREY GREENFIELD FOR PRE-CLINICAL RESEARCH ON EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES 17 1 PART I, LINE 2: THE ORGANIZATION PROVIDES FUNDS TO THE UNIVERSITY OF MINNESOTA AND OTHER RESEARCH HOSPITALS FOR RESEARCH AND TRAINING RELATING TO THE PREVENTION, TREATMENT AND CURE OF CHILDHOOD CANCER. THE BOARD OF DIRECTORS AND EXECUTIVE COMMITTEE MONITOR THE USE OF GRANT FUNDS. X X X X X 0 0 0 0 0 0 0 0 0 JEAN MACHART COO THROUGH SEPTEMBER 260067 0 0 0 0 0 7079 0 5018 0 272164 0 0 0 ELIZABETH ALLEN CEO 244491 0 0 0 0 0 7524 0 2350 0 254365 0 0 0 KENNA DOOLEY CHIEF DEVELOPMENT OFFICER 202605 0 0 0 0 0 5328 0 8864 0 216797 0 0 0 ERSKINE BEVEL DIRECTOR OF FINANCE 150270 0 0 0 0 0 0 0 13186 0 163456 0 0 0 X 86 2203199 US STOCK EXCHANGE X FURNITURE & EQUIPMENT 1 19905 FMV 0 0 0 FORM 990, PART VI, SECTION A, LINE 1A EXECUTIVE COMMITTEE: CCRF HAS AN EXECUTIVE COMMITTEE WHICH CONSISTS OF THE CHAIRPERSON, THE VICE CHAIRPERSON, THE VICE CHAIRPERSON ELECT, THE TREASURER, AND THE SECRETARY. THE CHAIRPERSON MAY ALSO APPOINT SUCH OTHER MEMBERS OF THE BOARD OF DIRECTORS TO THE EXECUTIVE COMMITTEE AS HE OR SHE DETERMINES APPROPRIATE. THE EXECUTIVE COMMITTEE SHALL HAVE THE POWERS TO ACT FOR AND ON BEHALF OF THE BOARD OF DIRECTORS DURING THE PERIODS BETWEEN MEETINGS OF THE BOARD OF DIRECTORS TO TAKE ANY ACT THAT MAY BE TAKEN BY THE BOARD OF DIRECTORS. THE EXECUTIVE COMMITTEE SHALL MEET AT REGULAR INTERVALS THROUGHOUT THE YEAR. THE CEO SHALL ATTEND THE MEETINGS OF THE EXECUTIVE COMMITTEE AS A NONVOTING PARTICIPANT. THE CORPORATION MAY EXCLUDE THE CEO FROM MEETINGS OF THE EXECUTIVE COMMITTEE OR ANY PORTION OF A MEETING OR FROM ACCESS TO RELATED MATERIALS. IN THE ABSENCE OF A NOMINATING COMMITTEE, THE EXECUTIVE COMMITTEE SHALL FULFILL THE PURPOSES OF THE NOMINATING COMMITTEE. FORM 990, PART VI, SECTION B, LINE 11B THE FINANCE, INVESTMENT & ADMINISTRATION COMMITTEE REVIEWS THE FORM 990 AND RECOMMENDS ITS APPROVAL TO THE EXECUTIVE COMMITTEE. THE BOARD OF DIRECTORS RECEIVES A COPY OF THE 990 FORM BEFORE IT IS FILED. FORM 990, PART VI, SECTION B, LINE 12C ALL BOARD OF DIRECTORS AND EMPLOYEES ARE REQUIRED TO REVIEW THE CONFLICT OF INTEREST POLICY AND SIGN AN ANNUAL DISCLOSURE STATEMENT. ALL FINANCIAL TRANSACTIONS AND CONTRACTS ARE REVIEWED BY THE DIRECTOR OF FINANCE AND, IF NECESSARY, THE CEO AND ATTORNEYS TO ENSURE NO TRANSACTIONS ARE EXECUTED THAT COULD BE INTERPRETED AS INTRODUCING A CONFLICT OF INTEREST. FORM 990, PART VI, SECTION B, LINE 15 ANNUALLY, THE EXECUTIVE COMMITTEE REVIEWS THE CEO'S COMPENSATION AND RECOMMENDS A SPECIFIC LEVEL OF COMPENSATION. A COMPREHENSIVE COMPENSATION STUDY FOR ALL ORGANIZATIONAL POSITIONS IS PERFORMED PERIODICALLY, WHICH COMPARES SALARIES FOR EACH JOB DESCRIPTION RELATIVE TO GEOGRAPHIC LOCATION, ORGANIZATIONAL SIZE AND TYPE. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC ON OUR WEBSITE. THE GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY CAN ALSO BE PROVIDED UPON REQUEST. FORM 990, PART XII, LINE 2C: THE PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR.